查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1663502

数位生物标记市场，按类型、按应用、按最终用途、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Digital Biomarkers Market, By Type, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年数位生物标记市场规模价值为 35.4054 亿美元，2025 年至 2032 年期间的复合年增长率为 22.90%。

数位生物标记市场-市场动态

越来越关注远端患者监控以推动市场成长

人们对远端病人监控（RPM）的日益关注极大地推动了数位生物标记市场的发展。 RPM 涉及使用数位技术（例如穿戴式装置、行动应用程式和感测器）来监测传统临床环境以外的患者健康状况。随着向以患者为中心的护理模式的转变以及慢性病的增多，RPM 使医疗保健提供者能够即时追踪患者的健康状况，从而及时干预并更好地管理糖尿病、高血压和心血管疾病等病症。推动 RPM 采用的关键因素是对个人化和持续医疗保健的需求不断增长。数位生物标记提供连续、即时的资料，从而实现更有针对性的治疗并改善患者的治疗效果。根据美国卫生与公众服务部的数据，RPM 已证明可将医院再入院率降低 25%，并透过减少亲自就诊的需求来降低医疗成本。这证明了 RPM 在改善病患照护和优化医疗资源利用方面的有效性。此外，持续的 COVID-19 疫情加速了远端监控的需求，患者和医疗保健提供者正在寻求比面对面就诊更安全的替代方案。慢性病的日益流行，加上穿戴式装置的技术进步，进一步推动了数位生物标记市场的发展，改变了医疗保健的未来。

数位生物标誌物市场-关键见解

  • 根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 22.90%
  • 根据类型细分，预计生理学将在 2024 年占据最大市场份额
  • 根据最终用途细分，医疗保健提供者是 2024 年的领先细分市场
  • 从地区来看，北美是 2024 年最大的收入来源

数位生物标记市场-細項分析：

全球数位生物标记市场根据类型、应用、最终用途和地区进行细分。

依类型，市场分为三类：生理、行为、认知。生理生物标记占据市场主导地位，因为它们能够提供即时、准确的生命体征洞察，例如心率、血压和体温，这对于监测慢性病至关重要。这些生物标记广泛应用于穿戴式装置和远端监控解决方案，使其成为个人化医疗的基石。

根据最终用途，市场分为三类：医疗保健提供者、製药公司、研究机构。医疗保健提供者在市场中占据主导地位，因为他们在利用数位生物标记进行患者监测、诊断和治疗优化方面发挥关键作用。他们采用这些技术，实现即时资料追踪、早期疾病检测和个人化治疗计划，从而增强患者护理，推动市场成长。

数位生物标记市场-地理洞察

数位生物标记市场表现出明显的地理差异，北美由于其先进的医疗基础设施、可穿戴技术的广泛采用以及政府对数位健康计划的不断增加的支持而引领市场。美国处于领先地位，这得益于慢性病的高发性、远距医疗的进步以及对医疗创新的大量投资。此外，美国政府的《21世纪治癒法案》等政策提倡使用数位健康工具，推动了数位生物标记的采用。欧洲紧随其后，因为该地区越来越重视以患者为中心的医疗保健和远端患者监控。德国和英国等国家越来越多地将数位生物标记融入临床实践，旨在加强个人化医疗并改善慢性病管理。在亚太地区，由于医疗保健支出的增加、人们对慢性病管理的认识的不断提高以及技术的进步，市场正在迅速扩张。日本、中国和印度等国家正在采用数位健康解决方案来管理日益加重的疾病负担并改善医疗保健服务。中东和非洲 (MEA) 也正在经历成长，儘管速度较慢，因为数位医疗的采用仍处于早期阶段，但随着政府支持的倡议和医疗保健系统的改善，其发展势头强劲。

数位生物标记市场-竞争格局：

数位生物标记市场的竞争格局由多种参与者组成，包括科技公司、医疗保健提供者和研究机构。该领域的公司正专注于创新和策略合作伙伴关係，以扩大其产品范围。主要参与者正在利用与医疗机构的合作，将数位生物标记整合到临床工作流程中，增强其在患者监测和疾病管理中的实用性。此外，随着企业寻求加强其市场地位和提高其技术能力，併购趋势也日益增长。该公司还专注于产品开发，采用先进的人工智慧演算法、机器学习和资料分析来提高数位生物标记的准确性和预测能力。市场高度分散，参与者在技术进步、易于整合、法规遵循和成本效益等因素上竞争。随着个人化医疗的重要性日益增加，数位生物标记正成为管理慢性病的关键组成部分，这推动了对创新解决方案的需求。此外，受穿戴式装置、行动应用程式和感测器技术进步的推动，市场正在见证大量新创企业的涌入，这对传统参与者提出挑战，迫使他们适应不断发展的医疗保健格局。

最新动态：

  • 2024 年 2 月，Biofourmis 与顶级製药公司达成了四项新协议，扩大了其在数位临床试验和数位生物标记开发中的作用，特别是在肿瘤学领域。该公司在数位生物标记和分散临床试验方面的专业知识正在推动其平台的采用，该平台旨在透过远端监控和上门服务缩短研究时间并增强参与者的参与度。
  • 2024 年 11 月，Neuron23 与罗氏合作，利用其数位生物标记和设备作为帕金森氏症 2 期 NEULARK 临床试验的主要终点。与传统临床评定量表相比，罗氏的 navify 数位生物标记解决方案可提供持续、客观的症状跟踪，从而提高精确度、减轻患者负担并提高临床试验效率。
  • 2024 年 12 月，Koneksa 发布了一种新的资料联合模型，旨在透过将数位健康资料用于临床和转化科学来增强药物发现。该模型促进了生物製药公司等利益相关者之间的合作，从而能够更快地启动研究并实现即时资料共享，以更有效地验证数位健康措施。 LEARNS 研究就体现了这种方法，该研究使用穿戴式装置和数位健康工具评估帕金森氏症的进展，以加快临床试验中数位生物标记的验证。

目录

第 1 章：数位生物标记物市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 数位生物标记物市场片段（按类型）
    • 数位生物标记物市场片段（按应用）
    • 数位生物标记物市场片段（依最终用途）
    • 各国数位生物标记市场概况
    • 数位生物标记物市场片段（按地区）
  • 竞争洞察

第 3 章：数位生物标记物关键市场趋势

  • 数位生物标记市场驱动因素
    • 市场驱动因素的影响分析
  • 数位生物标记市场限制
    • 市场限制的影响分析
  • 数位生物标记市场机会
  • 数位生物标记市场未来趋势

第 4 章：数位生物标记产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第五章：数位生物标记市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：数位生物标记市场格局

  • 2024 年数位生物标记市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：数位生物标记市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 生理
    • 行为
    • 认知的
    • 其他的

第 8 章：数位生物标记市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 穿戴式装置
    • 行动应用程式
    • 远端监控系统
    • 感测器技术
    • 其他的

第 9 章：数位生物标记物市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医疗保健提供者
    • 製药公司
    • 研究机构
    • 其他的

第 10 章：数位生物标记市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美数位生物标记物主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模及预测（依最终用途划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲数位生物标记物主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（依最终用途）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区数位生物标记主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（按类型）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用途划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲数位生物标记物主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按类型）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（依最终用途划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲数位生物标记主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模和预测（按类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用途划分）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：关键供应商分析-数位生物标记产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Biofourmis, Inc.
    • Roche Holding AG
    • Koneksa Health, Inc.
    • Philips Healthcare
    • Abbott Laboratories
    • Google LLC
    • Biogen, Inc.
    • Garmin Ltd.
    • Apple Inc.
    • Medtronic PLC
    • Chrono Therapeutics, Inc.
    • Senseonics Holdings, Inc.
    • Proteus Digital Health, Inc.
    • Omron Healthcare Co., Ltd.
    • ActiGraph, LLC
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4690

REPORT HIGHLIGHT

Digital Biomarkers Market size was valued at US$ 3,540.54 Million in 2024, expanding at a CAGR of 22.90% from 2025 to 2032.

Digital biomarkers are measurable indicators of biological processes, conditions, or diseases, which are captured and tracked using digital technologies such as wearables, mobile apps, and remote monitoring devices. These biomarkers provide real-time, continuous, and objective data about an individual's health status. Unlike traditional biomarkers, which are often derived from blood samples or clinical tests, digital biomarkers offer a more dynamic and non-invasive way to monitor health. The need for digital biomarkers arises from the growing demand for personalized healthcare and early disease detection. Traditional clinical visits can be infrequent, leading to gaps in understanding a patient's condition. Digital biomarkers bridge this gap by enabling continuous monitoring, helping detect health issues before they manifest with severe symptoms. They also facilitate timely interventions, improving patient outcomes. The importance of digital biomarkers lies in their potential to revolutionize healthcare. They provide accurate, real-time insights into an individual's health, allowing for personalized treatment plans and enabling the monitoring of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders. Furthermore, digital biomarkers can enhance clinical trials, offering better data for assessing drug efficacy and safety. They are also crucial in promoting preventive care by tracking early signs of diseases, thus helping in proactive health management.

Digital Biomarkers Market- Market Dynamics

Increasing focus on remote patient monitoring to drive the market growth

The growing focus on remote patient monitoring (RPM) is significantly driving the Digital Biomarkers market. RPM involves the use of digital technologies, such as wearables, mobile applications, and sensors, to monitor patients' health status outside of traditional clinical settings. With the shift towards more patient-centric care models and the rise of chronic diseases, RPM enables healthcare providers to track patient health in real-time, leading to timely interventions and better management of conditions such as diabetes, hypertension, and cardiovascular diseases. One key factor driving RPM adoption is the increasing demand for personalized and continuous healthcare. Digital biomarkers provide continuous, real-time data, allowing for more tailored treatments and improving patient outcomes. According to the U.S. Department of Health and Human Services, RPM has been shown to reduce hospital readmission rates by 25% and lower healthcare costs by reducing the need for in-person visits. This demonstrates the effectiveness of RPM in both improving patient care and optimizing healthcare resource utilization. Moreover, the ongoing COVID-19 pandemic has accelerated the need for remote monitoring, with patients and healthcare providers seeking safer alternatives to in-person visits. The growing prevalence of chronic diseases, coupled with technological advancements in wearable devices, further fuels the market for digital biomarkers, transforming the future of healthcare.

Digital Biomarkers Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.90% over the forecast period (2025-2032)
  • Based on Type segmentation, Physiological was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Healthcare Providers was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Digital Biomarkers Market- Segmentation Analysis:

The Global Digital Biomarkers Market is segmented on the basis of Type, Application, End-Use and Region.

The market is divided into three categories based on Type: Physiological, Behavioral, Cognitive. Physiological biomarkers dominate the market due to their ability to provide real-time, accurate insights into vital signs like heart rate, blood pressure, and temperature, which are essential for monitoring chronic conditions. These biomarkers are widely adopted in wearable devices and remote monitoring solutions, making them a cornerstone of personalized healthcare.

The market is divided into three categories based on End-Use: Healthcare Providers, Pharmaceutical Companies, Research Organizations. Healthcare Providers dominate the market due to their critical role in utilizing digital biomarkers for patient monitoring, diagnosis, and treatment optimization. Their adoption of these technologies enhances patient care by enabling real-time data tracking, early disease detection, and personalized treatment plans, driving market growth.

Digital Biomarkers Market- Geographical Insights

The Digital Biomarkers market shows significant geographical variation, with North America leading the market due to the presence of advanced healthcare infrastructure, widespread adoption of wearable technologies, and increasing government support for digital health initiatives. The U.S. is at the forefront, driven by the high prevalence of chronic diseases, advancements in telemedicine, and substantial investments in healthcare innovation. Moreover, the U.S. government's policies, such as the 21st Century Cures Act, promote the use of digital health tools, boosting the adoption of digital biomarkers. Europe follows closely, driven by the region's growing emphasis on patient-centered healthcare and remote patient monitoring. Countries like Germany and the UK are increasingly integrating digital biomarkers into clinical practice, aiming to enhance personalized medicine and improve chronic disease management. In the Asia-Pacific region, the market is expanding rapidly due to increasing healthcare spending, growing awareness about chronic disease management, and technological advancements. Countries like Japan, China, and India are adopting digital health solutions to manage the rising burden of diseases and improve healthcare access. The Middle East and Africa (MEA) are also witnessing growth, albeit at a slower pace, as digital health adoption is still in the early stages but gaining momentum with government-backed initiatives and improving healthcare systems.

Digital Biomarkers Market- Competitive Landscape:

The competitive landscape of the Digital Biomarkers market is marked by a diverse range of players, including technology companies, healthcare providers, and research organizations. Companies in this space are focusing on innovation and strategic partnerships to expand their offerings. Key players are leveraging collaborations with healthcare institutions to integrate digital biomarkers into clinical workflows, enhancing their utility in patient monitoring and disease management. Moreover, there is a growing trend of mergers and acquisitions as companies seek to strengthen their market position and enhance their technological capabilities. Companies are also focusing on product development, incorporating advanced AI algorithms, machine learning, and data analytics to improve the accuracy and predictive power of digital biomarkers. The market is highly fragmented, with players competing on factors such as technological advancement, ease of integration, regulatory compliance, and cost-effectiveness. With the increasing importance of personalized healthcare, digital biomarkers are becoming a crucial component in managing chronic conditions, which drives the demand for innovative solutions. Additionally, the market is witnessing an influx of startups, driven by advancements in wearable devices, mobile applications, and sensor technologies, challenging traditional players to adapt to the evolving healthcare landscape.

Recent Developments:

  • In February 2024, Biofourmis secured four new agreements with top pharmaceutical companies, expanding its role in digital clinical trials and the development of digital biomarkers, particularly in oncology. The company's expertise in digital biomarkers and decentralized clinical trials is driving the adoption of its platform, which aims to reduce study timelines and enhance participant engagement through remote monitoring and in-home services.
  • In November 2024, Neuron23 partnered with Roche to utilize its digital biomarker and device as a primary endpoint in the Phase 2 NEULARK clinical trial for Parkinson's disease. The use of Roche's navify digital biomarker solution will enhance precision, reduce patient burden, and improve clinical trial efficiency by offering continuous, objective symptom tracking compared to traditional clinical rating scales.
  • In December 2024, Koneksa published a new data syndication model to enhance drug discovery by using digital health data for clinical and translational science. The model facilitates collaboration among stakeholders like biopharmaceutical companies, enabling faster study launches and real-time data sharing to validate digital health measures more efficiently. This approach is exemplified by the LEARNS study, which is evaluating Parkinson's disease progression using wearable devices and digital health tools to speed up the validation of digital biomarkers in clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Biofourmis, Inc.
  • Roche Holding AG
  • Koneksa Health, Inc.
  • Philips Healthcare
  • Abbott Laboratories
  • Google LLC
  • Biogen, Inc.
  • Garmin Ltd.
  • Apple Inc.
  • Medtronic PLC
  • Chrono Therapeutics, Inc.
  • Senseonics Holdings, Inc.
  • Proteus Digital Health, Inc.
  • Omron Healthcare Co., Ltd.
  • ActiGraph, LLC
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Physiological
  • Behavioral
  • Cognitive
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Wearable Devices
  • Mobile Applications
  • Remote Monitoring Systems
  • Sensor Technologies
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Healthcare Providers
  • Pharmaceutical Companies
  • Research Organizations
  • Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Digital Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Biomarkers Market Snippet by Type
    • 2.1.2. Digital Biomarkers Market Snippet by Application
    • 2.1.3. Digital Biomarkers Market Snippet by End-Use
    • 2.1.4. Digital Biomarkers Market Snippet by Country
    • 2.1.5. Digital Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Biomarkers Key Market Trends

  • 3.1. Digital Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Biomarkers Market Opportunities
  • 3.4. Digital Biomarkers Market Future Trends

4. Digital Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Biomarkers Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Digital Biomarkers Market Landscape

  • 6.1. Digital Biomarkers Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Biomarkers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Physiological
    • 7.1.3. Behavioral
    • 7.1.4. Cognitive
    • 7.1.5. Others

8. Digital Biomarkers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Wearable Devices
    • 8.1.3. Mobile Applications
    • 8.1.4. Remote Monitoring Systems
    • 8.1.5. Sensor Technologies
    • 8.1.6. Others

9. Digital Biomarkers Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Healthcare Providers
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Research Organizations
    • 9.1.5. Others

10. Digital Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Digital Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Digital Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Digital Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Digital Biomarkers Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Digital Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Digital Biomarkers Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Biofourmis, Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Koneksa Health, Inc.
    • 11.2.4. Philips Healthcare
    • 11.2.5. Abbott Laboratories
    • 11.2.6. Google LLC
    • 11.2.7. Biogen, Inc.
    • 11.2.8. Garmin Ltd.
    • 11.2.9. Apple Inc.
    • 11.2.10. Medtronic PLC
    • 11.2.11. Chrono Therapeutics, Inc.
    • 11.2.12. Senseonics Holdings, Inc.
    • 11.2.13. Proteus Digital Health, Inc.
    • 11.2.14. Omron Healthcare Co., Ltd.
    • 11.2.15. ActiGraph, LLC
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us